Please login to the form below

Not currently logged in
Email:
Password:

UCB Pharma

This page shows the latest UCB Pharma news and features for those working in and with pharma, biotech and healthcare.

UCB looks to pipeline with five years left for twin blockbusters

UCB looks to pipeline with five years left for twin blockbusters

CEO outlines pipeline promise, won't write off post-Brexit UK. Mid-sized pharma company UCB has seen its epilepsy treatment Vimpat break through the $1bn+ annual revenues mark, joining its ... Jean-Christophe Tellier. Speaking to Pharma Market Europe

Latest news

  • UCB signs research deal with King’s College London UCB signs research deal with King’s College London

    Company and academic researchers to share one facility. UCB Pharma has boosted its R&D capabilities in the UK by signing a new 3-year collaboration with King’s College London ... UCB researchers will share labs with academics from KCL at Guy’s Campus

  • Communiqué: big wins for obesity and sugar tax campaigners Communiqué: big wins for obesity and sugar tax campaigners

    Meanwhile, Aurora Healthcare Communications’ Travel with IBD campaign for Japanese pharma group Takeda and charity Crohn’s &Colitis UK won an award in the Excellence in Healthcare Collaboration and Partnerships category. ... The internal campaign

  • Communiqué 2018 - all the winners Communiqué 2018 - all the winners

    Act on Fractures (frACTure) – World Osteoporosis Day 2017 by Chamberlain Healthcare PR, a Syneos Health Company, for UCB Pharma.

  • UCB launches online clinical trial tool UCB launches online clinical trial tool

    Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.

  • UCB supports social network for SpA patients UCB supports social network for SpA patients

    UCB to gain insights from a unique social network just for patients, enabling us to provide valuable resource that educate and support these patients.”. . ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations

More from news
Approximately 3 fully matching, plus 81 partially matching documents found.

Latest Intelligence

  • Digital health Digital health

    Clough says UCB is a role model for how pharma should approach digital health. ... UCB has stuck with it, putting the right team in place to see an end-to-end solution come to fruition - something that pharma doesn’t usually do.

  • A quest for innovative solutions A quest for innovative solutions

    Like many of the big pharmaceutical players, UCB is riding out from its well-appointed laboratories and gleaming head office corrals to prospect for pharma gold. ... Increase returns. UCB is one of the partners in a consortium that includes other EFPIA

  • Deal Watch table for November 2014 Deal Watch table for November 2014

    For an indepth analysis of these deals, read'Pharma deals during November 2014'. ... UCB (Kremers Urban Pharma) /Advent International and Avista Capital Partners. Generics portfolio.

  • VIDEO interview: Neil Weir, UCB VIDEO interview: Neil Weir, UCB

    I think that one of the main challenges of the pharma industry is not being terribly efficient. ... innovation approach to finding future treatments in key for UCB areas, such as neurology and autoimmue disorders.

  • Pharma deals during February 2013 Pharma deals during February 2013

    Another deal which featured an option this month is Leo Pharma's option to license 4SC Discovery's pre-clinical product for psoriasis. ... UCB Pharma [but not GSK]) pooling its research efforts with academics (in UK, Germany and Netherland) and SMEs in a

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • EPG Health EPG Health

    With an actionable reach of over a million HCPs globally, EPG Health provides customers (including most of the top 20 pharma companies) with an integrated toolset to:. ... Novartis, Orphan Europe, Philips, Pfizer, Roche, Sanofi, Takeda, UCB, Uriach,

  • Frontera Group Frontera Group

    Dreamskin Health . Eusa Pharma. Galderma . Gedeon Richter. Genzyme. Grunenthal . Leukaemia UK. ... Novartis Pharmaceuticals. Novex Pharma. Pfizer. Shire Pharmaceuticals. UCB . Vertex Pharmaceuticals.

  • How the focus on patient outcomes has allowed FMCG to enter into healthcare market

    Pharma companies are entering risk-sharing agreements in order to achieve higher reimbursement. ... So far UCB is the only pharma company who has engaged in a risk-sharing agreement with payer.

  • Representatives from Boehringer Ingelheim, Pfizer, UCB announced as judges for eyeforpharma Barcelona Awards

    Top pharma minds including C-Level executives from Boehringer Ingelheim, Baxter, Janssen and UCB, together with a range of notable academics and stakeholders, make up the panel. ... Adding to this sentiment, judge Lode Dewulf, Chief Patient Officer at

  • mXm Medical Communications mXm Medical Communications

    For example, the board game “Action Zone!” (for UCB Pharma), which won major Communiqué Awards in 2008, has already affected the lives of hundreds of thousands of children with epilepsy. ... 2005 Award of Excellence for Educational Video,

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...

Infographics